The headquarters of Amgen in Thousand Oaks, California, proudly displays the Amgen logo. The biotech company is venturing into the weight loss drug market with a unique approach, aiming to differentiate itself from competitors such as Novo Nordisk and Eli Lilly. Amgen’s injectable treatment, MariTide, not only aids in weight loss but also helps patients maintain their weight after discontinuing the drug. Additionally, the company is testing a less frequent dosing schedule, offering potential convenience over existing weekly medications. While it is uncertain how competitive Amgen will be in this market, analysts project the weight loss drug space to be worth $100 billion by the end of the decade. Source: www.cnbc.com
Published on 2024-03-25 12:03:02